Nxera Pharma Co Eulerpool Novinky

Nxera Pharma Co Eulerpool News

Nxera Pharma Co Novinky o akciách

Nxera Pharma Co sledujú mnohí novinári a investori po celom svete. Najaktuálnejšie správy Nxera Pharma Co zhromažďujeme práve tu.

• 2. septembra ·

  Yahoo
  Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
• 28. augusta ·

  Yahoo
  Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
• 9. augusta ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2024
• 9. júla ·

  Yahoo
  Nxera Pharma Webinar Presentation for Q2 FY2024 Financial Results
• 9. júla ·

  SeekingAlpha
  Neurocrine's Pipeline, Including Crinecerfont's Priority Review, Drives Long-Term Growth
• 27. júna ·

  Yahoo
  Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
• 18. júna ·

  Yahoo
  Nxera Pharma Publishes its Annual and ESG Reports for the Year ended 31 December 2023
• 30. mája ·

  Yahoo
  Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
• 30. mája ·

  Yahoo
  Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
• 9. mája ·

  Yahoo
  Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults